Trilaciclib Before Chemotherapy May Prevent Hematological Events—With Savings
AJMC,
Despite the many advances in cancer care, some adverse events (AEs) remain stubbornly common.
Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel
AJMC,
Objective: To assess the impact of CIPN on clinical and economic outcomes in women with mBC, initiating IV paclitaxel/ nab-paclit…
Clinical and Economic Burden of Intravenous Paclitaxel or nab-Paclitaxel for Metastatic Breast Cancer
AJMC,
, to September 30, 2018, were identified in the MarketScan Commercial and MarketScan Medicare Supplemental databases.